Rockefeller Capital Management L.P. Axonics, Inc. Transaction History

Rockefeller Capital Management L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 17, 2023	BUY	$52.6 - $67.34 $58,386 - $74,747	1,110 Added 41.04%	3,815 $208,000
Q4 2022 Mar 06, 2023	SELL	$59.56 - $76.6 $33,532 - $43,125	-563 Reduced 17.23%	2,705 $169,000
Q3 2022 Nov 02, 2022	BUY	$57.96 - $78.12 $159,969 - $215,611	2,760 Added 543.31%	3,268 $230,000
Q4 2021 Feb 14, 2022	SELL	$50.01 - $73.35 $1,650 - $2,420	-33 Reduced 6.1%	508 $28,000
Q3 2021 Nov 12, 2021	BUY	$59.21 - $78.66 $473 - $629	8 Added 1.5%	541 $35,000
Q2 2021 Aug 10, 2021	SELL	$51.39 - $66.9 $41,471 - $53,988	-807 Reduced 60.22%	533 $33,000
Q1 2021 May 11, 2021	BUY	$49.14 - $59.89 $65,847 - $80,252	1,340 New	1,340 $80,000
Q1 2020 May 12, 2020	SELL	$16.44 - $37.73 $3,288 - $7,545	-200 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$13.32 - $24.35 $2,664 - $4,870	200 New	200 $5,000

5.03M

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Rockefeller Capital Management L.P., based on Form 13F filings with the SEC.

Stay updated on Rockefeller Capital Management L.P. with notifications on news.